fluoxetine has been researched along with 9,10-dimethyl-1,2-benzanthracene in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arron, RJ; Bogdanovic, RP; Brandes, LJ; Fang, W; Hogg, GR; LaBella, FS; Tong, J; Warrington, RC; Zaborniak, CL | 1 |
| Elkhoely, AA; Kabel, AM | 1 |
| Ilhan, N; Ozercan, IH; Susam, S; Tatar, O | 1 |
3 other study(ies) available for fluoxetine and 9,10-dimethyl-1,2-benzanthracene
| Article | Year |
|---|---|
Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Amitriptyline; Animals; Antidepressive Agents; DNA; Fluoxetine; Lymphocyte Activation; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasms, Experimental | 1992 |
Ameliorative potential of fluoxetine/raloxifene combination on experimentally induced breast cancer.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Catalase; Fluoxetine; Humans; Interleukin-6; Malondialdehyde; Raloxifene Hydrochloride; Rats; Superoxide Dismutase; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2016 |
Is there any potential anticancer effect of raloxifene and fluoxetine on DMBA-induced rat breast cancer?
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Body Weight; Carcinogens; Enzyme-Linked Immunosorbent Assay; Female; Fluoxetine; Mammary Neoplasms, Experimental; Raloxifene Hydrochloride; Rats; Rats, Wistar; Weight Gain | 2019 |